Evidence map›Paper›PMID 40625361›Full record

ArticleFrontiers in medicine2025

Analysis of the effects of acetyl tributyl citrate on bone cancer based on network toxicology and molecular docking.

Lujun Jiang, Juncheng Shen, Jinghong Yang, Zi Wang, Lian Tang, Yuqi Li, Jialin Liu, Zhong Li, Yanshi Liu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lujun Jiang *Department of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Juncheng Shen *Department of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jinghong Yang *Department of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Zi WangDepartment of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Lian TangDepartment of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yuqi LiDepartment of Urology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jialin LiuDepartment of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
Zhong LiDepartment of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yanshi LiuDepartment of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acetyl tributyl citrate (ATBC) is a widely used environmental plasticizer that has raised concerns regarding its potential health effects, particularly its role in cancer development. Although ATBC is generally considered to have a safer profile compared to traditional phthalate-based plasticizers, research on its association with bone cancer remains limited. The aim of this study is to elucidate the complex effects of Acetyl tributyl citrate (ATBC) on bone cancer and to unravel the potential molecular mechanisms by which environmental pollutants influence the disease process. Methods: This study utilized multiple online databases to identify target genes associated with ATBC and bone cancer. Initially, protein-protein interaction (PPI) analysis and visualization of the intersecting genes were performed. Subsequently, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were conducted to explore the underlying mechanisms connecting the two conditions. Finally, molecular docking was employed to validate the interactions between these compounds and their respective targets. Results: Using the CHEMBL, SwissTarget Prediction, and TargetNet databases, we screened 193 genes associated with ATBC. Additionally, we identified 4,439 genes related to bone cancer through the GeneCards, OMIM, and TTD databases, resulting in 73 intersecting genes. After rigorous refinement utilizing the STRING platform and Cytoscape software, we identified five core targets: STAT3, EGFR, MMP9, MAPK1, and MMP2. Functional enrichment analysis indicated that the core targets of ATBC's influence on bone cancer are primarily involved in the regulation of apoptosis, carcinogenesis, and cellular proliferation, among other biological processes. Finally, molecular docking simulations conducted with AutoDock confirmed robust binding interactions between ATBC and these core targets, thereby enhancing our understanding of their interactions. Conclusion: This study underscores the potential carcinogenic effects of ATBC in bone cancer, identifying key targets such as STAT3, EGFR, MMP9, MAPK1, and MMP2. The findings indicate that ATBC may facilitate the progression of bone cancer by targeting essential signaling pathways and remodeling the tumor microenvironment. This emphasizes the necessity for further research into the environmental risks associated with this plasticizer.

Indexed as

acetyl tributyl citratebone cancermechanismmolecular dockingnetwork toxicology

Identifiers

PMID40625361
PMCPMC12230086

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.